BR112015007529A2 - material de ldh-ânions ativos aprimorado; uso de um material de ldh-ânions ativos aprimorado; método de produzir uma formulação com sabor, queimação ou irritação mascarados; e processo para a fabricação de materiais de ldh-ânions ativos aprimorados - Google Patents
material de ldh-ânions ativos aprimorado; uso de um material de ldh-ânions ativos aprimorado; método de produzir uma formulação com sabor, queimação ou irritação mascarados; e processo para a fabricação de materiais de ldh-ânions ativos aprimoradosInfo
- Publication number
- BR112015007529A2 BR112015007529A2 BR112015007529A BR112015007529A BR112015007529A2 BR 112015007529 A2 BR112015007529 A2 BR 112015007529A2 BR 112015007529 A BR112015007529 A BR 112015007529A BR 112015007529 A BR112015007529 A BR 112015007529A BR 112015007529 A2 BR112015007529 A2 BR 112015007529A2
- Authority
- BR
- Brazil
- Prior art keywords
- ldh
- anion
- active ldh
- materials
- active
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/52—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an inorganic compound, e.g. an inorganic ion that is complexed with the active ingredient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1611—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- General Preparation And Processing Of Foods (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1217911.5A GB201217911D0 (en) | 2012-10-05 | 2012-10-05 | Layered double hydroxides |
| PCT/GB2013/052554 WO2014053822A1 (en) | 2012-10-05 | 2013-10-01 | Layered double hydroxides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112015007529A2 true BR112015007529A2 (pt) | 2017-07-04 |
Family
ID=47294361
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112015007529A BR112015007529A2 (pt) | 2012-10-05 | 2013-10-01 | material de ldh-ânions ativos aprimorado; uso de um material de ldh-ânions ativos aprimorado; método de produzir uma formulação com sabor, queimação ou irritação mascarados; e processo para a fabricação de materiais de ldh-ânions ativos aprimorados |
Country Status (16)
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201520762D0 (en) * | 2015-11-24 | 2016-01-06 | Isis Innovation | Novel pharmaceutical compositions |
| JP6557597B2 (ja) * | 2015-12-25 | 2019-08-07 | 共栄社化学株式会社 | 層状複水酸化物 |
| US10882753B2 (en) | 2016-09-15 | 2021-01-05 | Paris Sciences Et Lettres—Quartier Latin | Method for exchanging interlayer anions of a layered double hydroxide |
| CN109432450B (zh) * | 2018-11-23 | 2021-07-13 | 北京化工大学 | 一种超分子纳米化学动力药物及其在肿瘤治疗方面的应用 |
| EP3957604B1 (en) * | 2019-04-19 | 2025-07-09 | National Institute for Materials Science | Nitrogen-based gas sustained release agent, nitrogen-based gas sustained release body comprising same, nitrogen-based gas sustained release method using sustained release body, breathing instrument, wrapping body, and sustained release device |
| CA3194835A1 (en) | 2020-10-17 | 2022-04-21 | David Anderson | Formulation and noncovalent stabilization of olivetolic acid derivatives |
| WO2025192959A1 (ko) * | 2024-03-13 | 2025-09-18 | 연세대학교 산학협력단 | 층상형 금속 인화물 혼성체 촉매, 이의 제조방법 및 이를 구비하는 수전해 장치 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS606619A (ja) | 1983-06-27 | 1985-01-14 | Kyowa Chem Ind Co Ltd | 鉄分欠乏症処置剤及びその製法 |
| US5079203A (en) | 1990-05-25 | 1992-01-07 | Board Of Trustees Operating Michigan State University | Polyoxometalate intercalated layered double hydroxides |
| JP3681480B2 (ja) * | 1996-09-27 | 2005-08-10 | エーザイ株式会社 | 薬物の不快な味を隠蔽する組成物 |
| GB0030460D0 (en) * | 2000-12-14 | 2001-01-24 | Isis Innovation | Drug delivery system |
| US6924409B2 (en) | 2000-12-19 | 2005-08-02 | Babcock & Wilcox Volund Aps | Method for reducing the leaching of oxyanion forming elements, in particular chromium, from hazardous waste |
| JP2004091421A (ja) * | 2002-09-03 | 2004-03-25 | Tayca Corp | アスコルビン酸を取り込んだ層状複水酸化物およびそれを含む化粧料組成物 |
| US20040138511A1 (en) | 2003-01-10 | 2004-07-15 | James Butler | Aromatic alkylation process with direct recycle |
| AU2003902178A0 (en) | 2003-05-07 | 2003-05-22 | Commonwealth Scientific And Industrial Research Organisation | Stabilization of waste material |
| CN1297276C (zh) | 2004-06-14 | 2007-01-31 | 北京化工大学 | 5－氨基水杨酸插层药物缓释剂及其制备方法 |
| US20090108233A1 (en) * | 2004-12-24 | 2009-04-30 | The Univeristy Of Queensland | Preparation of suspensions |
| US20060140994A1 (en) | 2004-12-27 | 2006-06-29 | Bagwell Alison S | Application of an antimicrobial agent on an elastomeric article |
| MY157620A (en) * | 2006-01-31 | 2016-06-30 | Cytochroma Dev Inc | A granular material of a solid water-soluble mixed metal compound capable of binding phosphate |
| CN100462071C (zh) * | 2006-09-22 | 2009-02-18 | 北京化工大学 | 一种磁性超分子插层结构缓释型布洛芬及其制备方法 |
| CN101493404B (zh) | 2008-01-21 | 2011-08-10 | 安徽帝元生物科技有限公司 | 一种化肥养分控失剂控失率的检测方法 |
| CN101440281B (zh) * | 2008-11-25 | 2011-11-23 | 北京化工大学 | 苯并咔唑插层水滑石复合发光材料及其制备方法 |
| ZA201000350B (en) | 2009-02-05 | 2010-12-29 | Univ Pretoria | A degradable polymeric material |
| CN101507819B (zh) * | 2009-03-27 | 2011-01-05 | 北京化工大学 | 一种大粒径药物插层水滑石及其制备方法 |
| CN101597474B (zh) | 2009-07-03 | 2012-10-17 | 北京化工大学 | 增甘磷插层结构选择性红外吸收材料及其制备方法与应用 |
| US20110040006A1 (en) | 2009-08-17 | 2011-02-17 | Basf Se | Compositions with Improved Dirt Pickup Resistance Comprising Layered Double Hydroxide Particles |
| CN102218043B (zh) | 2011-06-14 | 2013-03-27 | 宁夏医科大学 | Ldh超分子组装型阿司匹林缓释片及其制备方法 |
-
2012
- 2012-10-05 GB GBGB1217911.5A patent/GB201217911D0/en not_active Ceased
-
2013
- 2013-10-01 AU AU2013326298A patent/AU2013326298B2/en active Active
- 2013-10-01 KR KR1020157011694A patent/KR20150063559A/ko not_active Ceased
- 2013-10-01 CA CA2887059A patent/CA2887059A1/en not_active Abandoned
- 2013-10-01 EP EP15166388.7A patent/EP2929876B1/en active Active
- 2013-10-01 BR BR112015007529A patent/BR112015007529A2/pt not_active Application Discontinuation
- 2013-10-01 JP JP2015535105A patent/JP6363082B2/ja not_active Expired - Fee Related
- 2013-10-01 CN CN201380063531.9A patent/CN104853748A/zh active Pending
- 2013-10-01 WO PCT/GB2013/052554 patent/WO2014053822A1/en not_active Ceased
- 2013-10-01 IN IN2576DEN2015 patent/IN2015DN02576A/en unknown
- 2013-10-01 US US14/433,599 patent/US9642919B2/en active Active
- 2013-10-01 MX MX2015004188A patent/MX2015004188A/es unknown
- 2013-10-01 EP EP13771206.3A patent/EP2903598B1/en active Active
- 2013-10-01 EA EA201590673A patent/EA034124B1/ru active IP Right Revival
-
2015
- 2015-03-25 IL IL237947A patent/IL237947B/en active IP Right Grant
- 2015-04-06 PH PH12015500744A patent/PH12015500744B1/en unknown
- 2015-04-14 ZA ZA2015/02510A patent/ZA201502510B/en unknown
-
2017
- 2017-04-24 ZA ZA2017/02869A patent/ZA201702869B/en unknown
- 2017-08-23 AU AU2017219016A patent/AU2017219016B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| ZA201702869B (en) | 2018-08-29 |
| AU2013326298A1 (en) | 2015-04-23 |
| WO2014053822A1 (en) | 2014-04-10 |
| US9642919B2 (en) | 2017-05-09 |
| IL237947B (en) | 2018-04-30 |
| AU2017219016B2 (en) | 2018-07-26 |
| EP2903598A1 (en) | 2015-08-12 |
| PH12015500744A1 (en) | 2015-05-25 |
| CN104853748A (zh) | 2015-08-19 |
| EA034124B1 (ru) | 2019-12-30 |
| CA2887059A1 (en) | 2014-04-10 |
| EP2929876B1 (en) | 2019-12-25 |
| ZA201502510B (en) | 2017-09-27 |
| EA201590673A1 (ru) | 2015-08-31 |
| AU2013326298B2 (en) | 2017-10-05 |
| JP6363082B2 (ja) | 2018-07-25 |
| JP2016500667A (ja) | 2016-01-14 |
| GB201217911D0 (en) | 2012-11-21 |
| IN2015DN02576A (cg-RX-API-DMAC7.html) | 2015-09-11 |
| MX2015004188A (es) | 2015-07-17 |
| PH12015500744B1 (en) | 2015-05-25 |
| KR20150063559A (ko) | 2015-06-09 |
| US20150258212A1 (en) | 2015-09-17 |
| AU2017219016A1 (en) | 2017-09-07 |
| EP2903598B1 (en) | 2019-05-01 |
| EP2929876A1 (en) | 2015-10-14 |
| WO2014053822A4 (en) | 2014-05-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112013025519A2 (pt) | composição farmacêutica | |
| BR112012010706A2 (pt) | composto, composição farmacêutica, combinação do produto farmacêutico, uso de um composto, e, métodos para o tratamento de uma doença ou condição, e para inibir um bromodomínio | |
| BR112012026378A2 (pt) | processo para modificar pelo menos parte da superfície de pelo menos um material mineral, suspensão, filtro centrífugo ou torta, material mineral seco modificado na superfície, e, usos da suspensão, do filtro centrífugo ou da torta, ou do material mineral seco modificado na superfície, e de pelo menos um agente | |
| BR112014027181A2 (pt) | derivados de benzamida para a inibição da atividade de abl1, abl2 e bcr-abl1 | |
| BRPI0611886B8 (pt) | partículas que compreendem um dopante hidrofóbico e seu processo para fabricação e método para distribuir um dopante hidrofóbico | |
| BRPI0712631A8 (pt) | compostos, processos para a preparação de um composto, composição farmacêutica, uso de um composto e combinações | |
| BR112013026834A2 (pt) | composto, composição farmacêutica, produto farmacêutico de combinação, uso de um composto, e, método para tratar doenças ou condições e para inibir um bromodomínio | |
| BR112014026383A2 (pt) | derivados de benzamida para inibir a atividade de abl1, abl2 e bcr-abl1 | |
| BR112015013659A2 (pt) | processo para a conversão de materiais de estoque de alimentação de celulose | |
| BRPI1014275B8 (pt) | composição que compreende partículas de indometacina dispersas em pelo menos dois materiais de moagem parcialmente moídos | |
| BR112013023517A2 (pt) | "inibidores de produção de leucotrieno, seus usos, e composição farmacêutica" | |
| BR112013032711A2 (pt) | composições farmacêuticas compreendendo sulbactam e inibidor de beta-lactamase | |
| WO2014058637A3 (en) | Process for treating fly ash and a rotary mill therefor | |
| BR112014022214A2 (pt) | fenólicos antibacterianos | |
| BR112015007295A2 (pt) | processo para a preparação de compostos; compostos; e uso dos mesmos | |
| BR112013033388A2 (pt) | composição cimentícia e mistura | |
| BR112012025523A2 (pt) | composição dentária | |
| PH12015500744A1 (en) | Layered double hydroxides | |
| BR112015032129A2 (pt) | composição, sachê soluvel em água e processo de preparação da composição | |
| BR112013020841A2 (pt) | processo para preparar produtos que compreendem ativos estabilizados e composições que compreendem os mesmos | |
| NZ704023A (en) | Novel rebamipide prodrug, method for producing same, and usage thereof | |
| BR112013032910A2 (pt) | processo de acabamento de ureia | |
| BR112014000603A8 (pt) | Método para produzir suspensão coloidal de partículas de zircônia, suspensão coloidal transparente de zircônia e artigo óptico | |
| BR112018001035A2 (pt) | compostos de fenoxiacetamidas aneladas, sal farmaceuticamente aceitável, seu método de síntese, combinação de medicamento e uso dos mesmos | |
| BR112015006063A2 (pt) | compostos heteroaromáticos, processo para preparar os compostos, composições farmacêuticas, usos e método de tratamento para as dores aguda e crônica |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B06I | Publication of requirement cancelled [chapter 6.9 patent gazette] |
Free format text: ANULADA A PUBLICACAO CODIGO 6.6.1 NA RPI NO 2462 DE 13/03/2018 POR TER SIDO INDEVIDA. |
|
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
| B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
| B11B | Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements |